- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Financially Fit Penny Stocks
Swiss Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
2
0 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
2 companies
Molecular Partners
Market Cap: CHF 118.0m
A clinical-stage biotechnology company, designs and develops designed ankyrin repeat proteins therapeutics for the treatment of oncology diseases in Switzerland.
MOLN
CHF 3.20
7D
-4.6%
1Y
-5.9%
Addex Therapeutics
Market Cap: CHF 5.8m
Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland.
ADXN
CHF 0.059
7D
1.7%
1Y
-17.6%